Korro Bio
0 followers
KRRO
Performance
About Korro Bio
Korro Bio is a biotechnology company focused on advancing genetic medicines by editing RNA to modulate biological pathways. It develops a proprietary platform, OPERA®, to deliver chemically modified RNA that targets precise changes inside cells. The company highlights its work on rare and complex diseases, such as alpha-1 antitrypsin deficiency, and emphasizes a pipeline of drug candidates derived from RNA editing strategies. Based on its messaging, Korro Bio operates in the biopharmaceutical sector with activities centered on therapeutics development and genetic medicines.
Recent News
Recent Deals
No recent deals for this company.
